Origin Peptides Limited
Research and experimental development on biotechnology · Linlithgow
ActiveUnited KingdomIncorporated 2018Private Limited Company
Financial position
Accounts to 2025-09-30 · GBP · Company accounts
Net assets
−£255,983
Cash
—
Turnover
—
Profit / loss
—
Current assets
£449,717
Creditors < 1 year
—
Equity
−£255,983
Average employees
5
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
| Reported figures | 2025-09-30Company | 2024-09-30Company | 2023-09-30Company | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 |
|---|---|---|---|---|---|---|---|
| Balance sheet | |||||||
| Net assets | −£255,983 | £3,700 | −£23,185 | £7,017 | £30,630 | £33,507 | −£1,062 |
| Equity | −£255,983 | £3,700 | −£23,185 | £7,017 | £30,630 | £33,507 | −£1,062 |
| Assets | |||||||
| Fixed assets | £84,774 | £114,218 | £62,455 | £78,249 | £86,887 | £18,857 | £14,290 |
| Current assets | £449,717 | £18,573 | £1,355 | £3,799 | £13,380 | £62,260 | £54,531 |
| Liabilities | |||||||
| Creditors within one year | — | — | — | — | — | — | £69,883 |
| Net current assets | £228,740 | −£108,898 | −£80,131 | −£61,834 | −£43,195 | £14,650 | −£15,352 |
| Assets less current liabilities | £313,514 | £5,320 | −£17,676 | £16,415 | £43,692 | £33,507 | −£1,062 |
| People | |||||||
| Average employees | 5 | 4 | 3 | 3 | 3 | 3 | 0 |
| Source evidence | View filing | View filing | View filing | View filing | View filing | View filing | View filing |
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.